Cargando…

Misfolded G Protein-Coupled Receptors and Endocrine Disease. Molecular Mechanisms and Therapeutic Prospects

Misfolding of G protein-coupled receptors (GPCRs) caused by mutations frequently leads to disease due to intracellular trapping of the conformationally abnormal receptor. Several endocrine diseases due to inactivating mutations in GPCRs have been described, including X-linked nephrogenic diabetes in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ulloa-Aguirre, Alfredo, Zariñán, Teresa, Jardón-Valadez, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622668/ https://www.ncbi.nlm.nih.gov/pubmed/34830210 http://dx.doi.org/10.3390/ijms222212329

Ejemplares similares

Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases
por: Ulloa-Aguirre, Alfredo, et al.
Publicado: (2022)

Structure-Function Relationships of the Follicle-Stimulating Hormone Receptor
por: Ulloa-Aguirre, Alfredo, et al.
Publicado: (2018)

Molecular dynamics simulation of the follicle-stimulating hormone receptor. Understanding the conformational dynamics of receptor variants at positions N680 and D408 from in silico analysis
por: Jardón-Valadez, Eduardo, et al.
Publicado: (2018)

OR03-01 Functional Rescue Of Trafficking-Defective Mutant Follicle-Stimulating Hormone Receptors (FSHR) Leading To Premature Ovarian Failure With The Pharmacoperone CAN1405
por: Ulloa-Aguirre, Alfredo, et al.
Publicado: (2023)

OR08-4 A Novel Mutation in the Follicle-Stimulating Hormone Receptor (Ile423Thr) in a Woman with Normal Pubertal Development and Primary Amenorrhea: In Vivo, In Vitro, and In Silico Studies
por: Mayorga, Julio, et al.
Publicado: (2019)

Role of Cysteine Residues in the Carboxyl-Terminus of the Follicle-Stimulating Hormone Receptor in Intracellular Traffic and Postendocytic Processing
por: Melo-Nava, Brenda, et al.
Publicado: (2016)

A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis)
por: Gonzalez-Duarte, Alejandra, et al.
Publicado: (2021)

The Role of Endocrine G Protein-Coupled Receptors in Ovarian Cancer Progression
por: Zhang, Qingyu, et al.
Publicado: (2017)

Frequency of the T307A, N680S, and -29G>A single-nucleotide polymorphisms in the follicle-stimulating hormone receptor in Mexican subjects of Hispanic ancestry
por: García-Jiménez, Gabriela, et al.
Publicado: (2018)

In Vitro Impact of FSH Glycosylation Variants on FSH Receptor-stimulated Signal Transduction and Functional Selectivity
por: Zariñán, Teresa, et al.
Publicado: (2020)

OR08-4 Endocrine Mechanisms of an Orphan G Protein-Coupled Receptor Regulating Metabolic Homeostasis
por: Ren, Hongxia
Publicado: (2022)

Folding and misfolding pathways of G-quadruplex DNA
por: Marchand, Adrien, et al.
Publicado: (2016)

Molecular Mechanisms of Amylin Turnover, Misfolding and Toxicity in the Pancreas
por: Bhowmick, Diti Chatterjee, et al.
Publicado: (2022)

SAT-LB137 Rescue of Misfolded G-Protein Coupled Estrogen Receptor, GPER, from the Endoplasmic Reticulum via Natural and Synthetic Estrogens
por: Rouhimoghadam, Milad, et al.
Publicado: (2020)

Pharmacoperone Identification for Therapeutic Rescue of Misfolded Mutant Proteins
por: Conn, P. Michael, et al.
Publicado: (2011)

Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers
por: Kreiser, Ryan P., et al.
Publicado: (2020)

Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening
por: Maier, Esther M., et al.
Publicado: (2009)

Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
por: Prasad, Archana, et al.
Publicado: (2019)

Applications of molecular replacement to G protein-coupled receptors
por: Kruse, Andrew C., et al.
Publicado: (2013)

Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses
por: Galant, Natalie J., et al.
Publicado: (2016)

Engineering therapeutic antibodies targeting G-protein–coupled receptors
por: Jo, Migyeong, et al.
Publicado: (2016)

Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies
por: Ciechanover, Aaron, et al.
Publicado: (2015)

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
por: Takeuchi, Toshihide, et al.
Publicado: (2017)

Identification of Dysregulated Expression of G Protein Coupled Receptors in Endocrine Tumors by Bioinformatics Analysis: Potential Drug Targets?
por: Suteau, Valentine, et al.
Publicado: (2022)

Role of Protein Misfolding and Proteostasis Deficiency in Protein Misfolding Diseases and Aging
por: Cuanalo-Contreras, Karina, et al.
Publicado: (2013)

Corrigendum: Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses
por: Galant, Natalie J., et al.
Publicado: (2016)

Special Issue “G Protein-Coupled Receptors: Molecular Mechanisms Involved in Receptor Activation and Selectivity”
por: Miele, Rossella, et al.
Publicado: (2023)

PMON183 Impact of Small Negative Allosteric Modulators (NAM) of the Follicle-stimulating Hormone (FSH) Receptor on the Dynamics of the Transcriptome in Rat Granulosa Cells Exposed to Different FSH Glycosylation Variants.
por: Hernãndez-Ramírez, Laura, et al.
Publicado: (2022)

Prion Protein Misfolding
por: Kupfer, L, et al.
Publicado: (2009)

Protein misfolding diseases
por: Ventura, Salvador
Publicado: (2015)

Molecular Evolution of the Transmembrane Domains of G Protein-Coupled Receptors
por: Fatakia, Sarosh N., et al.
Publicado: (2011)

Molecular assembly of rhodopsin with G protein-coupled receptor kinases
por: He, Yuanzheng, et al.
Publicado: (2017)

How soluble misfolded proteins bypass chaperones at the molecular level
por: Halder, Ritaban, et al.
Publicado: (2023)

Cross-Seeding of Misfolded Proteins: Implications for Etiology and Pathogenesis of Protein Misfolding Diseases
por: Morales, Rodrigo, et al.
Publicado: (2013)

Treating Protein Misfolding Diseases: Therapeutic Successes Against Systemic Amyloidoses
por: Nevone, Alice, et al.
Publicado: (2020)

Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression
por: New, David C, et al.
Publicado: (2007)

Editorial: Protein misfolding, altered mechanisms and neurodegeneration
por: Gogia, Neha, et al.
Publicado: (2023)

Endocrine Therapeutics
Publicado: (1923)

Diverse Misfolded Conformational Strains and Cross-seeding of Misfolded Proteins Implicated in Neurodegenerative Diseases
por: Lim, Kwang Hun
Publicado: (2019)

Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
por: Belachew, Esmael Besufikad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ek13lk43933b1ko0812qkk6g4